$3.21
0.31% yesterday
Nasdaq, Aug 12, 10:00 pm CET
ISIN
CA88338H1001
Symbol
THTX

Theratechnologies Inc. Stock price

$3.21
+0.06 1.90% 1M
+1.59 98.15% 6M
+1.40 77.35% YTD
+1.87 139.55% 1Y
-5.47 63.02% 3Y
-7.71 70.60% 5Y
-4.27 57.09% 10Y
-2.37 42.48% 20Y
Nasdaq, Closing price Tue, Aug 12 2025
+0.01 0.31%
ISIN
CA88338H1001
Symbol
THTX
Industry

Key metrics

Basic
Market capitalization
$146.8m
Enterprise Value
$180.5m
Net debt
$33.7m
Cash
$9.9m
Shares outstanding
46.0m
Valuation (TTM | estimate)
P/E
negative | 37.3
P/S
1.7 | 1.8
EV/Sales
2.1 | 2.2
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
-47.4%
Return on Equity
32.9%
ROCE
70.1%
ROIC
195.8%
Debt/Equity
-1.6
Financials (TTM | estimate)
Revenue
$84.4m | $83.9m
EBITDA
$10.4m | $12.4m
EBIT
$8.5m | $11.2m
Net Income
$-9.2m | $4.0m
Free Cash Flow
$-3.1m
Growth (TTM | estimate)
Revenue
2.2% | -2.3%
EBITDA
49.2% | 28.6%
EBIT
125.2% | 36.8%
Net Income
-30.9% | 147.5%
Free Cash Flow
18.7%
Margin (TTM | estimate)
Gross
77.7%
EBITDA
12.4% | 14.7%
EBIT
10.1%
Net
-10.9% | 4.7%
Free Cash Flow
-3.7%
More
EPS
$-0.2
FCF per Share
$-0.1
Short interest
1.0%
Employees
103
Rev per Employee
$830.0k
Show more

Is Theratechnologies Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Theratechnologies Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Theratechnologies Inc. forecast:

9x Buy
90%
1x Hold
10%

Analyst Opinions

10 Analysts have issued a Theratechnologies Inc. forecast:

Buy
90%
Hold
10%

Financial data from Theratechnologies Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
May '25
+/-
%
84 84
2% 2%
100%
- Direct Costs 19 19
5% 5%
22%
66 66
5% 5%
78%
- Selling and Administrative Expenses 43 43
8% 8%
51%
- Research and Development Expense 14 14
26% 26%
17%
10 10
49% 49%
12%
- Depreciation and Amortization 1.95 1.95
39% 39%
2%
EBIT (Operating Income) EBIT 8.48 8.48
125% 125%
10%
Net Profit -9.16 -9.16
31% 31%
-11%

In millions USD.

Don't miss a Thing! We will send you all news about Theratechnologies Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Theratechnologies Inc. Stock News

Neutral
GlobeNewsWire
about one month ago
MONTREAL, July 09, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today reported business highlights and financial results for the second quarter 2025, ended May 31, 2025. All figures are in U.S. dollars unless otherwise stated.
Neutral
GlobeNewsWire
about one month ago
MONTREAL, July 03, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced the Company will report financial results for its second quarter 2025 ended May 31 on Wednesday, July 9, 2025.
Neutral
GlobeNewsWire
about one month ago
MONTREAL, July 02, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced that it has entered into a binding arrangement agreement with CB Biotechnology, LLC (the “Purchaser”), an affiliate of Future Pak, LLC (“Future Pak”), a privately held contract manufacturer, packager and...
More Theratechnologies Inc. News

Company Profile

Theratechnologies, Inc. is a pharmaceutical company. It engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Theratechnologies was founded on October 19, 1993 and is headquartered in Montreal, Canada.

Head office Canada
CEO Paul Lévesque
Employees 103
Founded 1993
Website www.theratech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today